Bruker (BRKR) Operating Income (2010 - 2026)

Bruker (BRKR) has reported Operating Income for 17 consecutive years, with -$65.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Income fell 648.74% year-over-year to -$65.3 million; the trailing twelve-month figure through Jun 2026 stood at -$30.6 million (down 116.64% YoY), and the FY2025 full-year result was $68.2 million, down 73.05% from the prior year.
• Operating Income slipped to -$65.3 million in Q2 2026 per BRKR's latest filing, from $10.2 million in the prior quarter.
• Across five years, Operating Income topped out at $131.3 million in Q3 2022 and bottomed at -$65.3 million in Q2 2026.
• Historically, Operating Income has averaged $63.1 million across 5 years, with a median of $73.0 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Operating Income grew 27.15% in 2023, then tumbled 648.74% in 2026.
• Over 5 years, Operating Income stood at $131.0 million in 2022, then dropped by 20.99% to $103.5 million in 2023, then plunged by 30.34% to $72.1 million in 2024, then climbed by 5.83% to $76.3 million in 2025, then tumbled by 185.58% to -$65.3 million in 2026.
• According to Business Quant data, Operating Income over the past three periods registered -$65.3 million, $10.2 million, and $76.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.